Triazolopyridinyl compounds as kinase inhibitors
TW202639547APending Publication Date: 2026-10-01BRISTOL MYERS SQUIBB CO
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115101244
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-14
- Filing Date
- 2026-01-13
- Publication Date
- 2026-10-01
Abstract
Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically acceptable salts thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.
Need to check novelty before this filing date? Find Prior Art